Author:
Pohjonen Jussi T.,Kaukinen Katri M.,Metso Martti J.,Nurmi Rakel KK.,Huhtala Heini SA.,Pörsti Ilkka H.,Mustonen Jukka T.,Mäkelä Satu M.
Abstract
Abstract
Background
Gastrointestinal (GI) symptoms are common in end-stage kidney disease. Mounting evidence indicates that the intestine plays an important role in the pathogenesis of IgA nephropathy (IgAN). However, no studies have addressed the obvious question; do IgAN patients suffer from GI symptoms?
Methods
Presence of GI symptoms and health-related quality of life were evaluated using the validated Gastrointestinal Symptom Rating Scale (GSRS) and Psychological General Well-Being (PGWB) questionnaires in 104 patients with kidney biopsy-verified IgAN and in 147 healthy controls. A person was regarded to experience ‘increased GI symptoms’ if the GSRS score exceeded plus 1 standard deviation of the mean of the corresponding score in the healthy controls.
Results
According to the GSRS total score, the IgAN patients had more GI symptoms than the healthy controls (2.0 vs. 1.7, p < 0.001). Female IgAN patients had higher GSRS total score than male patients (2.2 vs. 1.7, p = 0.001). More IgAN patients with preserved kidney function (eGFR > 60ml/min/1.73m2) suffered from increased symptoms of diarrhoea (76 vs. 25%, p = 0.028), constipation (81 vs. 19%, p = 0.046) and reflux (85 vs. 15%, p = 0.004) than did IgAN patients with reduced kidney function (eGFR < 60ml/min/1.73m2).
Conclusions
IgAN patients and especially female IgAN patients experienced more GI symptoms than healthy controls. More prevalent GI symptoms were already observed before kidney function was clearly reduced. Systematic enquiry of GI symptoms might increase the standard of care among IgAN patients. Moreover, GI symptoms may provide clues for future studies that examine the pathophysiology of IgAN.
Funder
the Competitive State Research Financing of the Expert Responsibility Area of Tampere University Hospital
Keliakialiitto
Finnish Society of Nephrology
Academy of Finland
Sigrid Juséliuksen Säätiö
Publisher
Springer Science and Business Media LLC
Reference47 articles.
1. Rodrigues JC, Haas M, Reich HN. IgA nephropathy. Clin J Am Soc Nephrol. 2017;12(4):677–86.
2. Coppo R. The intestine-renal connection in IgA nephropathy. Nephrol Dial Transplant. 2015;30(3):360–6.
3. Floege J, Feehally J. The mucosa-kidney axis in IgA nephropathy. Nat Rev Nephrol. 2016;12(3):147–56.
4. Rostoker G, Wirquin V, Terzidis H, et al. Mucosal Immun Prim Glomerulonephritis Nephron. 1993;63(3):286–90.
5. Rantala I, Collin P, Holm K, Kainulainen H, Mustonen J, Mäki M. Small bowel T cells, HLA class II antigen DR, and GroEL stress protein in IgA nephropathy. Kidney Int. 1999;55(6):2274–80.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献